Lexeo Therapeutics (LXEO) Earnings Date, Estimates & Call Transcripts $3.68 +0.01 (+0.27%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$3.59 -0.09 (-2.45%) As of 04/25/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexeo Therapeutics Earnings Summary Upcoming Earnings DateMay. 8EstimatedConsensus EPS (Mar. 24) -$0.87 Actual EPS (Mar. 24) -$0.78 Beat By $0.09 Lexeo Therapeutics released Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.78, which topped the consensus estimate of -$0.87 by $0.09. With a trailing EPS of -$3.08, Lexeo Therapeutics' earnings are expected to grow next year, from ($3.14) to ($2.78) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)LXEO Upcoming EarningsLexeo Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled on Wednesday, May 14, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Lexeo Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lexeo Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLXEO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Lexeo Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.80-$0.78-$0.79Q2 20252-$0.80-$0.80-$0.80Q3 20252-$0.79-$0.73-$0.76Q4 20252-$0.79-$0.66-$0.73FY 20258($3.18)($2.97)($3.08) Lexeo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------3/24/2025Q4 2024-$0.87-$0.78+$0.09-$0.78--8/12/2024--$0.64-$0.64--$0.64--5/9/2024Q1 2024-$0.76-$0.77 -$0.01-$0.77--3/11/2024Q4 2023-$0.71-$0.86 -$0.15-$0.86--12/11/2023Q3 2023-$0.96-$12.36 -$11.40-$12.36--10/30/2023Q2 2023--$8.30 -$8.30-$8.30-- Lexeo Therapeutics Earnings - Frequently Asked Questions When is Lexeo Therapeutics's earnings date? Lexeo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on LXEO's earnings history. Did Lexeo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lexeo Therapeutics (NASDAQ:LXEO) reported ($0.78) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.09. Learn more on analysts' earnings estimate vs. LXEO's actual earnings. How much revenue does Lexeo Therapeutics generate each year? Lexeo Therapeutics (NASDAQ:LXEO) has a recorded annual revenue of $650,000.00. How much profit does Lexeo Therapeutics generate each year? Lexeo Therapeutics (NASDAQ:LXEO) has a recorded net income of -$66.39 million. LXEO has generated -$3.08 earnings per share over the last four quarters. What is Lexeo Therapeutics's EPS forecast for next year? Lexeo Therapeutics's earnings are expected to grow from ($3.14) per share to ($2.78) per share in the next year. More Earnings Resources from MarketBeat Related Companies VERV Earnings Date PGEN Earnings Date MAZE Earnings Date AUTL Earnings Date ETON Earnings Date RVNC Earnings Date RAPP Earnings Date AMLX Earnings Date ZVRA Earnings Date MREO Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Markets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Market Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout This page (NASDAQ:LXEO) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
